CD8A and neoplasm: However, GD2.CAR T cells designed to express NAP delayed tumor outgrowth by generating a ‘hot’ TME with high infiltration of neutrophils, M1 macrophages, NK cells, CD8+ T cells, DCs, and a reduced number of Tregs [197], which potentiated GD2.CAR T cell therapy.